The time-course experiment using a bolus injection of waixA (Fig. 5) allowed us to design experiments that could determine whether this TRPM7 inhibitor would prove protective in an early-stage colon cancer mouse model. The gene discussed is TRPM7; the disease is malignant colon neoplasm.